HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Leaflet Laceration, an Extreme Measure to Avoid Coronary Occlusion After TAVR

Intentional leaflet laceration before mounting the prosthesis on the release system, so as to reduce the risk...
solaci -
Learn More
Structural heart disease

EuroPCR 2018 | SAPIEN 3 in bicuspids

First generation TAVR procedures performed on patients with bicuspid aortic valve stenosis have rendered suboptimal outcomes. In...
solaci -
Learn More
STRUCTURAL HEART DISEASE

EuroPCR 2018 | SENTINEL: Anatomical Predictors of Stroke during TAVR

The rate of cerebrovascular events in TAVR hovers about 4% in most of the current studies, regardless...
solaci -
Learn More
STRUCTURAL HEART DISEASE

EuroPCR 2018 | Meta-Analyzis on Cerebral Protection Devices during TAVR

The risk of stroke is inherent to TAVR and, apart from clinically manifest events, there is abundant...
solaci -
Learn More
Structural heart disease

EuroPCR 2018 | NOTION: Good TAVR Durability Compared with Surgically-Implanted Valve in Low-Risk Patients

Several studies are defining the role of transcatheter aortic valve replacement (TAVR) in patients with low surgical...
solaci -
Learn More
Structural heart disease

Is TAVR Durable Beyond 5 Years?

Courtesy of Dr. Carlos Fava. The benefits derived from transcatheter aortic valve replacement (TAVR) are clear and self-evident, and...
solaci -
Learn More
Structural heart disease

Baseline Pulmonary Hypertension Should Not Preclude TAVR

Pulmonary hypertension (PH) in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) should not...
solaci -
Learn More
Structural heart disease

Liver Failure as a Challenge for TAVR

Although surgical risk scores do not include liver failure (LF), patients who suffer from it and undergo...
solaci -
Learn More